Experts: Provide more funding for TB drugs, vaccines

Health experts on Thursday called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people worldwide last year. With the exception of Pfizer's rifabutin, a drug used to treat TB for those with drug-resistant HIV/AIDS, there have been no newly licensed drugs for TB in 40 years. Report